TAVR Update: What Have We Learned During The Past 10 Years?

https://www.Heart-Valve-Surgery.com - The use of transcatheter aortic valve replacement (TAVR) devices for aortic stenosis treatment has soared since this non-invasive therapy received its first FDA approval for inoperable patients in 2011. As you may know, TAVR does not require an incision to the patient's chest or ribs during the procedure.

However... Patients with aortic stenosis still have questions about the use of TAVR devices for aortic valve replacement. For that reason, we interviewed Dr. Allan Stewart, the Chief of Cardiac Surgery at Mercy Heart Institute in Miami, Florida, to learn more about the latest research and the newest innovations specific to TAVR.

Questions asked to Dr. Stewart in this video include:

1. Why did you choose to make TAVR a specialty in your practice?

2. Should TAVR be considered a "game changer" for patients with aortic stenosis? Why? Why not?

3. What are the top 3 patient benefits of TAVR compared to surgical aortic valve replacement (SAVR)?

4. What type of patient may be a candidate for TAVR?

5. What have been the results of your patients who receive a TAVR device?

6. What are the newest updates and developments specific to TAVR:
i. Low-risk patient use
ii. Stroke risk
iii. Paravalvular leak
iv. Pacemaker complications
v. New TAVR devices and delivery solutions

7. Can you talk about the prevalence of TAVR failure? How is it managed (SAVR or TAVR valve-in-valve)?

8. What is your #1 piece of advice for patients considering TAVR?

To learn more or schedule an appointment with Dr. Allan Stewart, please call (786) 755-1796 or visit https://www.heart-valve-surgery.com/surgeons/dr-Allan-Stewart-Miami-Florida.php.

Видео TAVR Update: What Have We Learned During The Past 10 Years? канала HeartValveSurgery.com